JPH08500610A - ペプチジル誘導体およびメタロプロテイナーゼ インヒビターとしてのそれらの使用 - Google Patents

ペプチジル誘導体およびメタロプロテイナーゼ インヒビターとしてのそれらの使用

Info

Publication number
JPH08500610A
JPH08500610A JP6524027A JP52402794A JPH08500610A JP H08500610 A JPH08500610 A JP H08500610A JP 6524027 A JP6524027 A JP 6524027A JP 52402794 A JP52402794 A JP 52402794A JP H08500610 A JPH08500610 A JP H08500610A
Authority
JP
Japan
Prior art keywords
group
formula
hydrogen atom
optionally substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6524027A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン モーフィー，リチャード
トーマス ミリカン，アンドリュー
Original Assignee
セルテック セラピューティックス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルテック セラピューティックス リミテッド filed Critical セルテック セラピューティックス リミテッド
Publication of JPH08500610A publication Critical patent/JPH08500610A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP6524027A 1993-04-27 1994-04-27 ペプチジル誘導体およびメタロプロテイナーゼ インヒビターとしてのそれらの使用 Pending JPH08500610A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939308695A GB9308695D0 (en) 1993-04-27 1993-04-27 Peptidyl derivatives
GB9308695.7 1993-04-27
PCT/GB1994/000896 WO1994025435A1 (fr) 1993-04-27 1994-04-27 Derives peptidiques et leur utilisation comme inhibiteurs de metalloproteases

Publications (1)

Publication Number Publication Date
JPH08500610A true JPH08500610A (ja) 1996-01-23

Family

ID=10734557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6524027A Pending JPH08500610A (ja) 1993-04-27 1994-04-27 ペプチジル誘導体およびメタロプロテイナーゼ インヒビターとしてのそれらの使用

Country Status (6)

Country Link
EP (1) EP0648206A1 (fr)
JP (1) JPH08500610A (fr)
AU (1) AU6575494A (fr)
CA (1) CA2139129A1 (fr)
GB (1) GB9308695D0 (fr)
WO (1) WO1994025435A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010523500A (ja) * 2007-04-02 2010-07-15 メルク フロスト カナダ リミテツド カテプシンｋインヒビターのアミド化調製方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
EP0905126B1 (fr) * 1994-01-22 2002-12-04 British Biotech Pharmaceuticals Limited Inhibiteurs de métalloprotéinase
GB2315750B (en) * 1994-01-22 1998-07-01 British Biotech Pharm Metalloproteinase inhibitors
AU711047B2 (en) * 1994-01-22 1999-10-07 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
ATE205184T1 (de) 1995-11-23 2001-09-15 British Biotech Pharm Metalloproteinase inhibitoren
ES2233275T3 (es) * 1995-12-08 2005-06-16 Agouron Pharmaceuticals, Inc. Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
IL121125A0 (en) * 1996-07-10 1997-11-20 American Cyanamid Co Mercaptoketones and mercaptoalcohols and their preparation
US5852213A (en) * 1996-07-10 1998-12-22 American Cyanamid Company Mercaptoketones and mercaptoalcohols and a process for their preparation
IL128337A0 (en) 1996-09-10 2000-01-31 British Biotech Pharm Cytostatic hydroxamic acid derivatives
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
ZA9818B (en) * 1997-01-07 1998-07-02 Abbott Lab C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
US5985911A (en) * 1997-01-07 1999-11-16 Abbott Laboratories C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
BR9813719A (pt) 1998-01-09 2000-10-17 Pfizer Agentes terapêuticos
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6288261B1 (en) 1998-12-18 2001-09-11 Abbott Laboratories Inhibitors of matrix metalloproteinases
WO2001070693A2 (fr) 2000-03-21 2001-09-27 The Procter & Gamble Company Inhibiteurs de metalloproteases d'acide difluorobutyrique
NZ520657A (en) 2000-03-21 2004-11-26 Procter & Gamble Heterocyclic side chain containing, N-substituted metalloprotease inhibitors
PL205134B1 (pl) * 2000-03-27 2010-03-31 Scripps Research Inst Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny
EP1406893B1 (fr) 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. COMPOSeS BICYCLIQUES DE PYRROLIDINE
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
RU2217196C2 (ru) * 2002-02-28 2003-11-27 Небольсин Владимир Евгеньевич Способ индукции дифференцировки клеток

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
ES2069833T3 (es) * 1990-12-03 1995-05-16 Celltech Ltd Derivados peptidilicos.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010523500A (ja) * 2007-04-02 2010-07-15 メルク フロスト カナダ リミテツド カテプシンｋインヒビターのアミド化調製方法

Also Published As

Publication number Publication date
GB9308695D0 (en) 1993-06-09
WO1994025435A1 (fr) 1994-11-10
EP0648206A1 (fr) 1995-04-19
AU6575494A (en) 1994-11-21
CA2139129A1 (fr) 1994-11-10

Similar Documents

Publication Publication Date Title
JPH08500610A (ja) ペプチジル誘導体およびメタロプロテイナーゼ インヒビターとしてのそれらの使用
JPH08500124A (ja) メタロプロテイナーゼインヒビターとしてのペプチジル誘導体
US6420427B1 (en) Aminobutyric acid derivatives
US5300501A (en) Peptidyl derivatives
US9018414B2 (en) Substituted 3-phenylpropionic acids and the use thereof
KR20010101402A (ko) 혈관 손상제로서 콜치놀 유도체
JPH11511137A (ja) コラーゲンの過剰生産に関係した疾患を治療するためのｃ−プロテイナーゼ阻害剤
JPWO1999019296A1 (ja) アミノブタン酸誘導体
JP2010248209A (ja) ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
JP2000515167A (ja) 基質メタロプロテアーゼ インヒビターとしてのホスフィン酸アミド
TWI232105B (en) Novel compounds and their preparation process and pharmaceutical formulation containing the same
AU4341393A (en) Sulphamide derivatives as metalloproteinase inhibitors
JPH09505038A (ja) マトリックスメタロプロテアーゼ阻害因子
JP2010519287A (ja) α−ハロシクロプロピルカルボキシ化合物およびα−アルキルシクロプロピルカルボキシ化合物ならびにそれらの使用
JPH09503492A (ja) スクシンアミド誘導体、それらの調製法及びそれらのゼラチナーゼ及びコラゲナーゼ阻害剤としての使用
JP4846150B2 (ja) 新規な２−デカルボキシ−２−ホスフィニコプロスタグランジンｆ類似体
NO20023058L (no) Oks(adi)azolyl-hydroksamsyrer nyttige som prokollagen c- proteinaseinhibitorer
KR20020002419A (ko) 4-아미노부탄산 유도체 및 그 유도체를 유효성분으로 하는약제
GB2378179A (en) Aromatic sulfonamides and their use in treating bacterial diseases
EA030709B1 (ru) Производное фенантролинфосфоновой кислоты и способ его получения и применения
AU609942B2 (en) Novel aspartate transcarbamylase inhibitors
EP2348865B1 (fr) Bêta-hydroxy-gamma-aminophosphonates, leurs méthodes de préparation et leur utilisation
JP3470692B2 (ja) アミノブタン酸誘導体
ES2240703T3 (es) Inhibidores de pcp de acido 3-heterociclilpropanohidroxamico.
JPH06506483A (ja) メタロプロテイナーゼ阻害剤としてのアミノ酸のホスホノ誘導体